The FDA's announcement paves the way for people to start receiving the vaccine at pharmacies and doctor's offices.
Tests on samples from bats, bat droppings, and fruit from the village and forested area where the first patient lived turned up no positives.
Bivalent boosters were first recommended for all Americans ages 12 and up in September 2022.
Infectious disease information from CIDRAP.
Discussion & analysis on the latest infectious disease developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and COVID-19 podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
"All of us know someone who has died from COVID in Minnesota. It's our grandpas and our grandmas, our moms and our dads, our brothers and our sisters and ... even our kids."
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.